Cargando…

Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease

Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertrand, Elodie, van Duinkerken, Eelco, Landeira-Fernandez, J., Dourado, Marcia C. N., Santos, Raquel L., Laks, Jerson, Mograbi, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472652/
https://www.ncbi.nlm.nih.gov/pubmed/28670272
http://dx.doi.org/10.3389/fnagi.2017.00182
_version_ 1783244152323964928
author Bertrand, Elodie
van Duinkerken, Eelco
Landeira-Fernandez, J.
Dourado, Marcia C. N.
Santos, Raquel L.
Laks, Jerson
Mograbi, Daniel C.
author_facet Bertrand, Elodie
van Duinkerken, Eelco
Landeira-Fernandez, J.
Dourado, Marcia C. N.
Santos, Raquel L.
Laks, Jerson
Mograbi, Daniel C.
author_sort Bertrand, Elodie
collection PubMed
description Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer’s disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers’ quality of life.
format Online
Article
Text
id pubmed-5472652
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54726522017-06-30 Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease Bertrand, Elodie van Duinkerken, Eelco Landeira-Fernandez, J. Dourado, Marcia C. N. Santos, Raquel L. Laks, Jerson Mograbi, Daniel C. Front Aging Neurosci Neuroscience Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer’s disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers’ quality of life. Frontiers Media S.A. 2017-06-16 /pmc/articles/PMC5472652/ /pubmed/28670272 http://dx.doi.org/10.3389/fnagi.2017.00182 Text en Copyright © 2017 Bertrand, van Duinkerken, Landeira-Fernandez, Dourado, Santos, Laks and Mograbi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Bertrand, Elodie
van Duinkerken, Eelco
Landeira-Fernandez, J.
Dourado, Marcia C. N.
Santos, Raquel L.
Laks, Jerson
Mograbi, Daniel C.
Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title_full Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title_fullStr Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title_full_unstemmed Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title_short Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
title_sort behavioral and psychological symptoms impact clinical competence in alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472652/
https://www.ncbi.nlm.nih.gov/pubmed/28670272
http://dx.doi.org/10.3389/fnagi.2017.00182
work_keys_str_mv AT bertrandelodie behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT vanduinkerkeneelco behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT landeirafernandezj behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT douradomarciacn behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT santosraquell behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT laksjerson behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease
AT mograbidanielc behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease